SDG 3: Good Health & Well-being
UN Sustainable Development Goal 3: SDG 3: Good Health & Well-being. Targets, indicators, ESG alignment, and corporate reporting guidance.
UN Sustainable Development Goal 3: SDG 3: Good Health & Well-being. Targets, indicators, ESG alignment, and corporate reporting guidance.
Goal: Ensure healthy lives and promote well-being for all at all ages
The COVID-19 pandemic exposed critical gaps in global health systems and reversed decades of progress on health indicators. Non-communicable diseases account for 74% of global deaths. Mental health conditions affect one in eight people worldwide. Access to essential health services remains inequitable, with significant disparities between and within countries.
Key targets include reducing maternal mortality (3.1), ending preventable deaths of newborns and children (3.2), ending epidemics of communicable diseases (3.3), reducing premature mortality from non-communicable diseases (3.4), strengthening prevention and treatment of substance abuse (3.5), halving global deaths from road traffic accidents (3.6), ensuring universal access to sexual and reproductive health services (3.7), achieving universal health coverage (3.8), and reducing deaths from hazardous chemicals and pollution (3.9).
Businesses contribute through occupational health and safety programmes, employee wellness initiatives (including mental health support), responsible marketing of health-related products, pharmaceutical access and affordability programmes, reducing pollution and hazardous substance exposure, and health-focused product innovation. The pharmaceutical, healthcare, food, and chemical sectors face particular expectations around SDG 3 alignment.
GRI 403 (Occupational Health and Safety), GRI 416 (Customer Health and Safety), SASB Healthcare sector standards, SASB Food & Beverage standards. The Access to Medicine Index benchmarks pharmaceutical companies on medicine access.
WHO, The Lancet, Global Health Observatory